At 8% CAGR, Global Pneumonia Therapeutics Market Will Reach USD 25.67 Billion by 2026: Facts & Factors

According to the [190+ Pages] research report; the global Pneumonia Therapeutics Market in 2019 was approximately USD 14.99 Billion. The market is expected to grow at a CAGR of 8% and is anticipated to reach around USD 25.67 Billion by 2026. Top market players are Bayer AG, Lupin Pharmaceuticals, Inc., Abbott, Allergan, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, and Merck & Co. and others.

New York, NY, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Facts and Factors have published a new research report titled *“Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026”*.

“According to the research study, the global Pneumonia Therapeutics Market was estimated at USD 14.99 Billion in 2019 and is expected to reach USD 25.67 Billion by 2026. The global Pneumonia Therapeutics Market is expected to grow at a compound annual growth rate (CAGR) of 8% from 2019 to 2027”.

Pneumonia is a severe inflammation of the lungs. It can be fatal in some people, particularly the elderly and those with respiratory disorders. COVID-19, a disease caused by a novel coronavirus, can spread to the lungs, causing pneumonia. The disease associated with the new coronavirus was originally referred to as novel coronavirus-infected pneumonia (NCIP). It was renamed COVID-19 by the World Health Organization, short for coronavirus disease in 2019. The ongoing COVID-19 pandemic has a positive impact on the demand patterns in the pneumonia therapeutics industry.

*Request Your Free Sample Report of Pneumonia Therapeutics Market @ *https://www.fnfresearch.com/sample/pneumonia-therapeutics-market-by-product-type-drugs-branded*         *

*(The free sample of this report is readily available on request).*

*Our Free Sample Report Includes:             *

•* *2020 Updated Report Introduction, Overview, and In-depth industry analysis

• 190+ Pages Research Report (Inclusion of Updated Research)

• Provide Chapter-wise guidance on Request

• 2020 Updated Regional Analysis with Graphical Representation of Size, Share & Trends

• Includes Updated List of table & figures

• Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis

• Facts and Factors research methodology

*(Note: The sample of this report is updated with COVID-19 impact analysis before delivery)*

*Key Offerings:*

· Market Size & Forecast by Revenue | 2020−2027
· Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities
· Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography
· Competitive Landscape – Top key vendors and other prominent vendors

*Inquire more about this report before purchase @ *https://www.fnfresearch.com/inquiry/pneumonia-therapeutics-market-by-product-type-drugs-branded             
*(You may enquire a report quote OR available discount offers to our sales team before purchase.)*

Increasing numbers of cases are expected to boost the growth of the global market for pneumonia therapy. The global pneumonia therapeutics industry is expected to offer huge opportunities to producers, vendors, and customers around the globe. The growing prevalence of community-acquired pneumonia, particularly among younger individuals, is also a key factor contributing to market growth. Additionally, a Consistent increase in funding opportunities for research for the development of new products is expected to broaden the scope for growth over the coming years.

*Top Market Players*

Key players operating in the pneumonia therapeutics market not restricted to include Bayer AG, Lupin Pharmaceuticals, Inc., Abbott, Allergan, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, and Merck & Co., Inc. Key operating players in the global pneumonia therapeutics market are aiming towards the mergers and acquisitions in order to get the competitive edge in the market. For instance, Merck & Co., Inc. is focusing on the development of the V114 pneumococcal vaccine currently under investigation in phase II trials.

*To know an additional revised 2020 list of market players, request a sample report:* https://www.fnfresearch.com/sample/pneumonia-therapeutics-market-by-product-type-drugs-branded

The global pneumonia therapeutics market is segmented on the basis of product type and region. On the basis of product type, the global pneumonia therapeutics market is divided into drugs, vaccines, and oxygen therapy. The drugs category is further divided into branded and generics. The branded drug category includes Aminopenicillins, Quinolones, Macrolides, B-lactamase inhibitors, Cephalosporins, Tetracyclines, Glycopeptide antibiotics, Carbapenems, and Others. The generic drug category includes Quinolones, Macrolides, and Others.

The outbreak of the COVID-19 epidemic across the globe has a positive impact on the global pneumonia therapeutics market. Increasing numbers of cases are anticipated to boost the growth of the global pneumonia therapeutics market. The global pneumonia therapeutics industry is expected to offer huge opportunities to manufacturers, vendors, and customers across the globe. Improved prevalence of pneumococcal disease is a high impact factor. Over the years, there has been a significant increase in the number of community-acquired and ventilator-associated bacterial pneumonia. Further, the growing prevalence of community-acquired pneumonia, particularly among younger individuals, is also a key factor contributing to market growth.

Browse the full *“Pneumonia Therapeutics Market by Product Type (Drugs (Branded and Generics), Vaccines, and Oxygen Therapy), and Regions: Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2020–2026"* report at https://www.fnfresearch.com/pneumonia-therapeutics-market-by-product-type-drugs-branded

The global pneumonia therapeutics market is segmented on the basis of product type and region. On the basis of product type, the global pneumonia therapeutics market is divided into drugs, vaccines, and oxygen therapy. The drugs category is further divided into branded and generics. The branded drug category includes Aminopenicillins, Quinolones, Macrolides, B-lactamase inhibitors, Cephalosporins, Tetracyclines, Glycopeptide antibiotics, Carbapenems, and Others. The generic drug category includes Quinolones, Macrolides, and Others.

Based upon the region the global market has been categorized as North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa. North America is expected to dominate in the global market in terms of revenue as compared to that of markets in other regions during the forecast period 2020-2026. This is attributed to growing incidences of COVID -19, growth in the geriatric population, increasing multidrug resistance in adults & children that reiterates the need for the development of advanced generation therapeutics in the region. Asia Pacific is anticipated to grow at a significant CAGR in the near future. The growth in the Asia Pacific countries is owing to the increasing occurrence of pneumococcal disease, unmet medical needs, increased antimicrobial tolerance, and increased conditions leading to a compromised immune system in the countries of the Asia Pacific.

*Request Customized Copy of Report @ *https://www.fnfresearch.com/customization/pneumonia-therapeutics-market-by-product-type-drugs-branded

*(We customize your report according to your research need. Ask our sales team for report customization.)*

*This report segments the pneumonia therapeutics market as follows:*

*Global Pneumonia Therapeutics Market: By Product Type*

· Drugs

· Branded

· Quinolones
· Aminopenicillins
· Macrolides
· B-lactamase inhibitors
· Cephalosporins
· Tetracyclines
· Glycopeptide antibiotics
· Carbapenems
· Others

· Generics

· Quinolones
· Macrolides
· Others

· Vaccines
· Oxygen Therapy

*Related Reports:*

*Bladder Cancer Therapeutics Market: *https://www.fnfresearch.com/bladder-cancer-therapeutics-market-by-cancer-type-transitional-947

*Pediatric And Adult Hemoconcentrators Market: *https://www.fnfresearch.com/pediatric-and-adult-hemoconcentrators-market-by-type-adult-992

*Clinical Trials Market:* https://www.fnfresearch.com/global-clinical-trials-market-by-phase-phase-i-1004

*Allergy Diagnostics Market:* https://www.fnfresearch.com/allergy-diagnostics-market-by-product-type-luminometers-assay

*Hepatorenal Syndrome Treatment Market: *https://www.fnfresearch.com/hepatorenal-syndrome-treatment-market-by-treatment-therapeutics-and

*About Facts & Factors (FnF Research):*

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

*Follow Us LinkedIn:* https://www.linkedin.com/company/fnfresearch

*Follow Us Twitter: *https://twitter.com/fnfresearch

*Contact Us:*

Facts & Factors

USA: +1-347-989-3985

*Email:* sales@fnfresearch.com

*Web:* https://www.fnfresearch.com

* Blog:* http://fnfnewsblog.com